The CRO for CNS
The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.
Substance Use Disorders
Rare and Ultra-Rare CNS Diseases
Bringing new therapies to patients living with mental health, neurological and substance use disorders.
Experience, Scientific Knowledge and Operational Expertise Combine With Accountability, Responsibility and Integrity
Latest News & Updates
T3D Therapeutics selects Clinilabs Drug Development Corporation as contract research organization partner for Phase 2 trial of T3D-959 in patients with Alzheimer’s Disease.
T3D Therapeutics, Inc. (“T3D Therapeutics” or the “Company”), a biopharmaceutical company specializing in the development of ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough [...]
By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the [...]
Clinilabs Drug Development Corporation Achieves CNS Trial Start-Up in 1/3 the Time of Industry Standard
Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) [...]
A PATIENT-CENTRIC APPROACH TO CLINICAL TRIALS
Volunteers & Patients
We empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation.
NEW POSSIBILITIES FOR
Clinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!